Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03046927 · ClinicalTrials.gov registry record · Phase 2

Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes

A Phase 2 study of Type 1 Diabetes, sponsored by Benjamin U. Nwosu, MD.

Completed
Registry status
Phase 2
Development phase
48
Enrollment target
1
Study location

NCT03046927 is a Phase 2 study of Type 1 Diabetes that has completed, run by Benjamin U. Nwosu, MD. The registered enrollment target is 48 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03046927, a Phase 2 study of Type 1 Diabetes, has completed, sponsored by Benjamin U. Nwosu, MD.

COMPLETED
Registry status
Phase 2
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

This project is designed to study the role of vitamin D supplementation on the honeymoon phase of type 1 diabetes in children who are on standardized insulin treatment. The results could lead to significant changes in the approach to the early phase of type 1 diabetes with a strong emphasis on prolonging the honeymoon phase by using vitamin D and maintaining these patients on a standardized insulin regimen. The overall goal is to reduce the long-term complications of type 1 diabetes.

Conditions Studied

Type 1 Diabetes

Interventions

  • OTHER Placebo
  • DRUG Ergocalciferol

Study Locations (1)

Massachusetts

  • University of Massachusetts Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2017-10-19
Est. Completion 2021-04-20
Phase Phase 2

Sponsor

Benjamin U. Nwosu, MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03046927

The ClinicalTrials.gov registry entry for NCT03046927 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (94% lower). The listed sponsor is Benjamin U. Nwosu, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03046927 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03046927 about?

NCT03046927 is a clinical study titled "Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes". This project is designed to study the role of vitamin D supplementation on the honeymoon phase of type 1 diabetes in children who are on standardized insulin treatment. The results could lead to significant changes in the approach to the early phase of type 1 diabetes with a strong emphasis on prolo...

What is the current status of trial NCT03046927?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2017-10-19. Estimated completion is 2021-04-20.

What conditions does trial NCT03046927 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT03046927?

The interventions under investigation include: Placebo (OTHER), Ergocalciferol (DRUG).

Who is sponsoring clinical trial NCT03046927?

This trial is sponsored by Benjamin U. Nwosu, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03046927 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 1 Diabetes

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.